Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Brief Communication

  • Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the <sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer
    You have access
    Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer
    Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klinger, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo di Santo and Irene J. Virgolini
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 859-862; DOI: https://doi.org/10.2967/jnumed.122.264977
  • [<sup>177</sup>Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement
    You have access
    [177Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement
    Josefine Graef, Stephanie Bluemel, Winfried Brenner, Holger Amthauer, Peter Truckenmueller, David Kaul, Peter Vajkoczy, Julia S. Onken and Christian Furth
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 892-895; DOI: https://doi.org/10.2967/jnumed.122.264850
  • Safety and Survival Outcomes of <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior <sup>223</sup>Ra treatment: The RALU Study
    Open Access
    Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study
    Kambiz Rahbar, Markus Essler, Kim M. Pabst, Matthias Eiber, Christian la Fougère, Vikas Prasad, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph A. Bundschuh, Wolfgang P. Fendler, Milena Kurtinecz, Anja Schmall, Frank Verholen and Oliver Sartor
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 574-578; DOI: https://doi.org/10.2967/jnumed.122.264456
  • Novel <sup>68</sup>Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
    Open Access
    Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
    Tristan T. Demmert, Ines Maric, Kelsey L. Pomykala, Katharina Lueckerath, Jens Siveke, Benedikt M. Schaarschmidt, Rainer Hamacher, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 368-371; DOI: https://doi.org/10.2967/jnumed.122.264872
  • You have access
    177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
    Thorsten Derlin, Liam Widjaja, Rudolf A. Werner and Frank M. Bengel
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 54-58; DOI: https://doi.org/10.2967/jnumed.122.264293
  • An Experimental Generator for Production of High-Purity <sup>212</sup>Pb for Use in Radiopharmaceuticals
    Open Access
    An Experimental Generator for Production of High-Purity 212Pb for Use in Radiopharmaceuticals
    Ruth Gong Li, Vilde Yuli Stenberg and Roy Hartvig Larsen
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 173-176; DOI: https://doi.org/10.2967/jnumed.122.264009
  • Feasibility of <sup>99m</sup>Tc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
    You have access
    Feasibility of 99mTc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
    Daniel Koehler, Markus Sauer, Susanne Klutmann, Ivayla Apostolova, Wencke Lehnert, Lars Budäus, Sophie Knipper and Tobias Maurer
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 59-62; DOI: https://doi.org/10.2967/jnumed.122.263892
  • In Vivo Visualization and Quantification of Neutrophil Elastase in Lungs of COVID-19 Patients: A First-in-Humans PET Study with <sup>11</sup>C-NES
    Open Access
    In Vivo Visualization and Quantification of Neutrophil Elastase in Lungs of COVID-19 Patients: A First-in-Humans PET Study with 11C-NES
    Gunnar Antoni, Mark Lubberink, Jens Sörensen, Elin Lindström, Mathias Elgland, Olof Eriksson, Michael Hultström, Robert Frithiof, Anders Wanhainen, Jonathan Sigfridsson, Paul Skorup and Miklos Lipcsey
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 145-148; DOI: https://doi.org/10.2967/jnumed.122.263974
  • You have access
    18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
    Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack and Val J. Lowe
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1887-1890; DOI: https://doi.org/10.2967/jnumed.122.263902
  • Dual-Tracer PET/CT Protocol with [<sup>18</sup>F]-FDG and [<sup>68</sup>Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept
    You have access
    Dual-Tracer PET/CT Protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept
    Katrin S. Roth, Conrad-Amadeus Voltin, Lutz van Heek, Simone Wegen, Klaus Schomäcker, Thomas Fischer, Simone Marnitz, Alexander Drzezga and Carsten Kobe
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1683-1686; DOI: https://doi.org/10.2967/jnumed.122.263835

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 10
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire